Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors. - KENET, G.; LUBETSKY, A.; LUBOSHITZ, J.; RAVID, B.; TAMARIN, I.; VARON, D.; MARTINOWITZ, U. (Haemophilia, 2009)